Metformin Use Was Associated With Reduced Risk of Incidental Sjögren's Syndrome in Patients With Type 2 Diabetes: A Population-Based Cohort Study

Metformin Use Was Associated With Reduced Risk of Incidental Sjögren's Syndrome in Patients With Type 2 Diabetes: A Population-Based Cohort Study

Purpose: Previous studies have shown that metformin exhibits an anti-inflammatory effect and may decrease the risk of incidental diabetes. But the effect of metformin on incidental Sjögren's syndrome is unknown. The aim of the study was to examine the association between metformin exposure and...

Full description

Bibliographic Details
Main Authors: Cheng-You Wang, Jung-Nien Lai, Chin-Hsiu Liu, Kai-Chieh Hu, Kai-Lun Sheu, James Cheng-Chung Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
metformin
Sjögren's syndrome
retrospective
cohort
National Health Insurance Research Database (NHIRD)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.796615/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.796615/full

Similar Items